These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 28401012)

  • 1. NRSN2 promotes osteosarcoma cell proliferation and growth through PI3K/Akt/MTOR and Wnt/β-catenin signaling.
    Keremu A; Maimaiti X; Aimaiti A; Yushan M; Alike Y; Yilihamu Y; Yusufu A
    Am J Cancer Res; 2017; 7(3):565-573. PubMed ID: 28401012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NRSN2 promotes non-small cell lung cancer cell growth through PI3K/Akt/mTOR pathway.
    Zhang XY; Kuang JL; Yan CS; Tu XY; Zhao JH; Cheng XS; Ye XQ
    Int J Clin Exp Pathol; 2015; 8(3):2574-81. PubMed ID: 26045763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Down-Regulated NRSN2 Promotes Cell Proliferation and Survival Through PI3K/Akt/mTOR Pathway in Hepatocellular Carcinoma.
    Wang X; Han L; Zhang J; Xia Q
    Dig Dis Sci; 2015 Oct; 60(10):3011-8. PubMed ID: 26055238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NRSN2 promotes breast cancer metastasis by activating PI3K/AKT/mTOR and NF-κB signaling pathways.
    Ren F; Zhang W; Lu S; Ren H; Guo Y
    Oncol Lett; 2020 Jan; 19(1):813-823. PubMed ID: 31885716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone Marrow Mesenchymal Stem Cells-Derived Extracellular Vesicles Promote Proliferation, Invasion and Migration of Osteosarcoma Cells via the lncRNA MALAT1/miR-143/NRSN2/Wnt/β-Catenin Axis.
    Li F; Chen X; Shang C; Ying Q; Zhou X; Zhu R; Lu H; Hao X; Dong Q; Jiang Z
    Onco Targets Ther; 2021; 14():737-749. PubMed ID: 33564242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Highly expressed NRSN2 is related to malignant phenotype in ovarian cancer.
    Tang W; Ren A; Xiao H; Sun H; Li B
    Biomed Pharmacother; 2017 Jan; 85():248-255. PubMed ID: 27908706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The exosomal transfer of human bone marrow mesenchymal stem cell-derived miR-1913 inhibits osteosarcoma progression by targeting NRSN2.
    Zhou J; Xu L; Yang P; Lu Y; Lin S; Yuan G
    Am J Transl Res; 2021; 13(9):10178-10192. PubMed ID: 34650689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurensin-2 promotes proliferation, invasion and migration of colorectal cancer cells via interaction with SOX12.
    Wang G; Yang K
    Oncol Lett; 2020 Dec; 20(6):389. PubMed ID: 33193849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Highly-expressed P2X7 receptor promotes growth and metastasis of human HOS/MNNG osteosarcoma cells via PI3K/Akt/GSK3β/β-catenin and mTOR/HIF1α/VEGF signaling.
    Zhang Y; Cheng H; Li W; Wu H; Yang Y
    Int J Cancer; 2019 Aug; 145(4):1068-1082. PubMed ID: 30761524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long non-coding RNA CRNDE promotes heptaocellular carcinoma cell proliferation by regulating PI3K/Akt /β-catenin signaling.
    Tang Q; Zheng X; Zhang J
    Biomed Pharmacother; 2018 Jul; 103():1187-1193. PubMed ID: 29864897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased expression of Neurensin-2 correlates with poor prognosis in hepatocellular carcinoma.
    Ma HQ; Liang XT; Zhao JJ; Wang H; Sun JC; Chen YB; Pan K; Xia JC
    World J Gastroenterol; 2009 Oct; 15(38):4844-8. PubMed ID: 19824122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Down-regulated PLAC8 promotes hepatocellular carcinoma cell proliferation by enhancing PI3K/Akt/GSK3β/Wnt/β-catenin signaling.
    Zou L; Chai J; Gao Y; Guan J; Liu Q; Du JJ
    Biomed Pharmacother; 2016 Dec; 84():139-146. PubMed ID: 27643556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NRSN2 is a Prognostic Biomarker in Gastric Cancer and Facilitates the Growth and Migration of Gastric Cancer Cells.
    Ren S; Chen M; Chen Y; Ding K
    Protein Pept Lett; 2023; 30(5):427-438. PubMed ID: 36918782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miRNA-125b regulates apoptosis of human non-small cell lung cancer via the PI3K/Akt/GSK3β signaling pathway.
    Wang Y; Zhao M; Liu J; Sun Z; Ni J; Liu H
    Oncol Rep; 2017 Sep; 38(3):1715-1723. PubMed ID: 28713974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. β-Elemonic acid inhibits the growth of human Osteosarcoma through endoplasmic reticulum (ER) stress-mediated PERK/eIF2α/ATF4/CHOP activation and Wnt/β-catenin signal suppression.
    Zhao A; Zhang Z; Zhou Y; Li X; Li X; Ma B; Zhang Q
    Phytomedicine; 2020 Apr; 69():153183. PubMed ID: 32113150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inactive Wnt/beta-catenin pathway in conventional high-grade osteosarcoma.
    Cai Y; Mohseny AB; Karperien M; Hogendoorn PC; Zhou G; Cleton-Jansen AM
    J Pathol; 2010 Jan; 220(1):24-33. PubMed ID: 19882675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Highly expressed UNC119 promotes hepatocellular carcinoma cell proliferation through Wnt/β-catenin signaling and predicts a poor prognosis.
    Lei B; Chai W; Wang Z; Liu R
    Am J Cancer Res; 2015; 5(10):3123-34. PubMed ID: 26693064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GPNMB silencing suppresses the proliferation and metastasis of osteosarcoma cells by blocking the PI3K/Akt/mTOR signaling pathway.
    Jin R; Jin YY; Tang YL; Yang HJ; Zhou XQ; Lei Z
    Oncol Rep; 2018 Jun; 39(6):3034-3040. PubMed ID: 29620278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Wnt/β-Catenin Signaling Activates Expression of the Bone-Related Transcription Factor RUNX2 in Select Human Osteosarcoma Cell Types.
    Vega OA; Lucero CMJ; Araya HF; Jerez S; Tapia JC; Antonelli M; Salazar-Onfray F; Las Heras F; Thaler R; Riester SM; Stein GS; van Wijnen AJ; Galindo MA
    J Cell Biochem; 2017 Nov; 118(11):3662-3674. PubMed ID: 28370561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Molecular mechanisms of resistance to phosphatidyl inositol 3-kinase inhibitors in triple-negative breast cancer cells].
    Zhang WL; Ma WJ; Chen S; Wu XZ; Zhang HR; Zhang JH
    Zhonghua Zhong Liu Za Zhi; 2016 Aug; 38(8):578-88. PubMed ID: 27531477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.